HROW Q1 2022 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$22M+43.2% YoY

Gross Profit

$16M73.0% margin

Operating Income

$2M9.5% margin

Net Income

-$2M-11.0% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

$967,000

Free Cash Flow

$563,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$98M

Total Liabilities

$88M

Stockholders' Equity

$10M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$15M	+43.2%
Gross Profit	$16M	$12M	+38.4%
Operating Income	$2M	$3M	-28.0%
Net Income	-$2M	$217,000	-1223.5%

Revenue Segments

Other Revenues

$2M100%